跳至主要内容
临床试验/IRCT2013052813505N1
IRCT2013052813505N1已完成2 期

ong-term effect of topical Dorzolamide and Latanoprost on Refraction in patients with primary open-angle glaucoma

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 149 years(—)
性别
All

入选标准

  • all patients with open angle glaucoma; older than 16; with eye pressure of 21 to 30 mm Hg which have not taken any treatment.
  • Exclusion criteria: previous use of systemic or topical dorsolamide; using contact lens since 1 month ago; taking sulfa drug since 1 month ago; lactation; pregnancy (pregnancy reduce eye pressure and increase cornea thickness); cataract; any kind of eye surgery; CD/disc more than 0.8; best visually by less than 20/40 (with using Pin Hole); any neuropathy, any severe damage to visual field; and also any increase in eye pressure more than 30 mm Hg during the study.

排除标准

  • 未提供

研究者

相似试验